191 related articles for article (PubMed ID: 31396656)
21. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.
Pati S; Khakoo AY; Zhao J; Jimenez F; Gerber MH; Harting M; Redell JB; Grill R; Matsuo Y; Guha S; Cox CS; Reitz MS; Holcomb JB; Dash PK
Stem Cells Dev; 2011 Jan; 20(1):89-101. PubMed ID: 20446815
[TBL] [Abstract][Full Text] [Related]
22. Atorvastatin enhances endothelial adherens junctions through promoting VE-PTP gene transcription and reducing VE-cadherin-Y731 phosphorylation.
Huo Z; Kong Y; Meng M; Cao Z; Zhou Q
Vascul Pharmacol; 2019 Jun; 117():7-14. PubMed ID: 29894844
[TBL] [Abstract][Full Text] [Related]
23. N-cadherin signaling via Trio assembles adherens junctions to restrict endothelial permeability.
Kruse K; Lee QS; Sun Y; Klomp J; Yang X; Huang F; Sun MY; Zhao S; Hong Z; Vogel SM; Shin JW; Leckband DE; Tai LM; Malik AB; Komarova YA
J Cell Biol; 2019 Jan; 218(1):299-316. PubMed ID: 30463880
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine kinase receptor B protects against coronary artery disease and promotes adult vasculature integrity by regulating Ets1-mediated VE-cadherin expression.
Jiang H; Huang S; Li X; Li X; Zhang Y; Chen ZY
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):580-8. PubMed ID: 25633318
[TBL] [Abstract][Full Text] [Related]
25. VE-cadherin trans-interactions modulate Rac activation and enhancement of lung endothelial barrier by iloprost.
Birukova AA; Tian Y; Dubrovskyi O; Zebda N; Sarich N; Tian X; Wang Y; Birukov KG
J Cell Physiol; 2012 Oct; 227(10):3405-16. PubMed ID: 22213015
[TBL] [Abstract][Full Text] [Related]
26. Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase.
Xu M; Waters CL; Hu C; Wysolmerski RB; Vincent PA; Minnear FL
Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1309-18. PubMed ID: 17670896
[TBL] [Abstract][Full Text] [Related]
27. Evidence of a common mechanism of disassembly of adherens junctions through Gα13 targeting of VE-cadherin.
Gong H; Gao X; Feng S; Siddiqui MR; Garcia A; Bonini MG; Komarova Y; Vogel SM; Mehta D; Malik AB
J Exp Med; 2014 Mar; 211(3):579-91. PubMed ID: 24590762
[TBL] [Abstract][Full Text] [Related]
28. PKCα activation of p120-catenin serine 879 phospho-switch disassembles VE-cadherin junctions and disrupts vascular integrity.
Vandenbroucke St Amant E; Tauseef M; Vogel SM; Gao XP; Mehta D; Komarova YA; Malik AB
Circ Res; 2012 Aug; 111(6):739-49. PubMed ID: 22798526
[TBL] [Abstract][Full Text] [Related]
29. Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells.
Gorbunova E; Gavrilovskaya IN; Mackow ER
J Virol; 2010 Jul; 84(14):7405-11. PubMed ID: 20463083
[TBL] [Abstract][Full Text] [Related]
30. hnRNPA2/B1 Ameliorates LPS-Induced Endothelial Injury through NF-
Chen Y; Tang D; Zhu L; Yuan T; Jiao Y; Yan H; Yu W
Mediators Inflamm; 2020; 2020():6458791. PubMed ID: 32565727
[TBL] [Abstract][Full Text] [Related]
31. A local VE-cadherin and Trio-based signaling complex stabilizes endothelial junctions through Rac1.
Timmerman I; Heemskerk N; Kroon J; Schaefer A; van Rijssel J; Hoogenboezem M; van Unen J; Goedhart J; Gadella TW; Yin T; Wu Y; Huveneers S; van Buul JD
J Cell Sci; 2015 Aug; 128(16):3041-54. PubMed ID: 26116572
[TBL] [Abstract][Full Text] [Related]
32. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF.
Nottebaum AF; Cagna G; Winderlich M; Gamp AC; Linnepe R; Polaschegg C; Filippova K; Lyck R; Engelhardt B; Kamenyeva O; Bixel MG; Butz S; Vestweber D
J Exp Med; 2008 Nov; 205(12):2929-45. PubMed ID: 19015309
[TBL] [Abstract][Full Text] [Related]
33. Rab5-mediated VE-cadherin internalization regulates the barrier function of the lung microvascular endothelium.
Yang J; Yao W; Qian G; Wei Z; Wu G; Wang G
Cell Mol Life Sci; 2015 Dec; 72(24):4849-66. PubMed ID: 26112597
[TBL] [Abstract][Full Text] [Related]
34. Differential regulation of endothelial cell permeability by high and low doses of oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine.
Starosta V; Wu T; Zimman A; Pham D; Tian X; Oskolkova O; Bochkov V; Berliner JA; Birukova AA; Birukov KG
Am J Respir Cell Mol Biol; 2012 Mar; 46(3):331-41. PubMed ID: 21997484
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial cadherin expression in lung specimens of patients with sepsis-induced acute respiratory distress syndrome and endothelial cell cultures.
Herwig MC; Tsokos M; Hermanns MI; Kirkpatrick CJ; Müller AM
Pathobiology; 2013; 80(5):245-51. PubMed ID: 23635392
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of VE-cadherin proteasomal degradation attenuates microvascular hyperpermeability.
Sawant DA; Tharakan B; Adekanbi A; Hunter FA; Smythe WR; Childs EW
Microcirculation; 2011 Jan; 18(1):46-55. PubMed ID: 21166925
[TBL] [Abstract][Full Text] [Related]
37. Urinary trypsin inhibitor attenuates LPS-induced endothelial barrier dysfunction by upregulation of vascular endothelial-cadherin expression.
Chen J; Wang J; Su C; Qian W; Sun L; Sun H; Chen J; Zhang H; Zhang J
Inflamm Res; 2016 Mar; 65(3):213-24. PubMed ID: 26681130
[TBL] [Abstract][Full Text] [Related]
38. eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases.
Di Lorenzo A; Lin MI; Murata T; Landskroner-Eiger S; Schleicher M; Kothiya M; Iwakiri Y; Yu J; Huang PL; Sessa WC
J Cell Sci; 2013 Dec; 126(Pt 24):5541-52. PubMed ID: 24046447
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
40. S-nitrosylation regulates VE-cadherin phosphorylation and internalization in microvascular permeability.
Guequén A; Carrasco R; Zamorano P; Rebolledo L; Burboa P; Sarmiento J; Boric MP; Korayem A; Durán WN; Sánchez FA
Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H1039-44. PubMed ID: 26921435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
